Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
The closing price of Nektar Therapeutics (NASDAQ: NKTR) was $0.75 for the day, down -5.89% from the previous closing price of $0.80. In other words, the price has decreased by -$5.89 from its previous closing price. On the day, 2.45 million shares were traded.
Ratios:
Our analysis of NKTR’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 3.24 and its Current Ratio is at 3.24. In the meantime, Its Debt-to-Equity ratio is 13.59 whereas as Long-Term Debt/Eq ratio is at 12.00.
On March 14, 2025, Oppenheimer Upgraded its rating to Outperform which previously was Perform but kept the price unchanged to $6.
On January 08, 2025, B. Riley Securities started tracking the stock assigning a Buy rating and target price of $4.B. Riley Securities initiated its Buy rating on January 08, 2025, with a $4 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on May 19 ’25 when Zalevsky Jonathan sold 10,712 shares for $0.67 per share. The transaction valued at 7,177 led to the insider holds 305,892 shares of the business.
Wilson Mark Andrew sold 9,996 shares of NKTR for $6,697 on May 19 ’25. The Chief Legal Officer now owns 314,296 shares after completing the transaction at $0.67 per share. On May 19 ’25, another insider, ROBIN HOWARD W, who serves as the President & CEO of the company, sold 23,208 shares for $0.67 each. As a result, the insider received 15,549 and left with 1,063,693 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 1.60 while its Price-to-Book (P/B) ratio in mrq is 10.15.
Stock Price History:
Over the past 52 weeks, NKTR has reached a high of $1.52, while it has fallen to a 52-week low of $0.43. The 50-Day Moving Average of the stock is 10.57%, while the 200-Day Moving Average is calculated to be -23.73%.
Shares Statistics:
A total of 186.10M shares are outstanding, with a floating share count of 179.42M. Insiders hold about 3.59% of the company’s shares, while institutions hold 64.59% stake in the company.
